ProCE Banner Activity

Accurately Diagnosing Bipolar Depression

Clinical Thought

Many patients with bipolar depression first present in a depressive episode and may be inaccurately diagnosed with unipolar depression. How can we tease out the correct diagnosis and initiate effective treatment for these patients? Dr Greg Mattingly provides guidance on identifying and managing bipolar depression in patients who present as depressed or with mixed symptoms.

Released: July 06, 2022

Expiration: July 05, 2023

No longer available for credit.

Share

Faculty

Greg W. Mattingly

Greg W. Mattingly, MD

Associate Clinical Professor
Department of Psychiatry
Washington University School of Medicine
President
St. Charles Psychiatry Associates
St. Louis, Missouri

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Intra Cellular Therapies

Faculty Disclosure

Primary Author

Greg W. Mattingly, MD

Associate Clinical Professor
Department of Psychiatry
Washington University School of Medicine
President
St. Charles Psychiatry Associates
St. Louis, Missouri

Greg W. Mattingly, MD: speaker fees: AbbVie, Alkermes, Corium, Eisai, Intracellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sunovion, Supernus, Takeda, Trispharma; consulting fees: AbbVie, Acadia, Alkermes, Axsome, Corium, Eisai, Ironshore, Intracellular, Janssen, Lundbeck, Neos, Neurocrine, Noven, Otsuka, Redax, Roche, Rhodes, Sage, Sirona, Sunovion, Supernus, Takeda, Teva, Trispharma; funds for research support: AbbVie, Acadia, Alkermes, Akili, Axsome, Boehringer, Emalex, Idorsia, Janssen, Karuna, Lumos Labs, Medgenics, NLS-1 Pharma AG, Redax, Relmada, Roche, Sage, Sirtsei, Sunovion, Supernus, Takeda, Teva.